dipyridamole has been researched along with Macular Degeneration in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Macular Degeneration: Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Age related macular degeneration is the leading cause of blindness in the developed world." | 1.46 | AICAR suppresses TNF-α-induced complement factor B in RPE cells. ( Chung, EJ; Efstathiou, NE; Konstantinou, EK; Maidana, DE; Miller, JW; Vavvas, DG; Young, LH, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, EJ | 1 |
| Efstathiou, NE | 1 |
| Konstantinou, EK | 1 |
| Maidana, DE | 1 |
| Miller, JW | 1 |
| Young, LH | 1 |
| Vavvas, DG | 1 |
1 other study available for dipyridamole and Macular Degeneration
| Article | Year |
|---|---|
AICAR suppresses TNF-α-induced complement factor B in RPE cells.
Topics: Aminoimidazole Carboxamide; Cell Line; Clustered Regularly Interspaced Short Palindromic Repeats; Co | 2017 |